Asosiy kontentga oʻtish
AkademScholar

Kashfiyot

Xizmatlar

Identifikatsiya

Ishlab chiquvchilar uchun

Ekotizim

Muassasalar

McGill University Health Centre

Nom variantlari: Centre universitaire de santé McGill · MUHC

Davlat:
CA
ROR:
https://ror.org/04cpxjv19
4
h-indeks
117
Iqtiboslar
48
Asarlar
113
Mualliflar
Vaqt boʻyicha

Vaqt boʻyicha tahlil

Iqtibos sharhi

Yillar boʻyicha nashrlar (ustun) va iqtiboslar (chiziq)

  • Nashrlar
  • Iqtiboslar
0358100613192520172018201920202021202220232024202520262017: Nashrlar 3, Iqtiboslar 12018: Nashrlar 6, Iqtiboslar 22019: Nashrlar 2, Iqtiboslar 62020: Nashrlar 8, Iqtiboslar 62021: Nashrlar 4, Iqtiboslar 152022: Nashrlar 3, Iqtiboslar 182023: Nashrlar 3, Iqtiboslar 42024: Nashrlar 4, Iqtiboslar 202025: Nashrlar 2, Iqtiboslar 252026: Nashrlar 2, Iqtiboslar 19

Iqtibos tarixi

0613192520172018201920202021202220232024202520262017: Iqtiboslar 12018: Iqtiboslar 22019: Iqtiboslar 62020: Iqtiboslar 62021: Iqtiboslar 152022: Iqtiboslar 182023: Iqtiboslar 42024: Iqtiboslar 202025: Iqtiboslar 252026: Iqtiboslar 19

Nashr tarixi

03581020172018201920202021202220232024202520262017: Nashrlar 32018: Nashrlar 62019: Nashrlar 22020: Nashrlar 82021: Nashrlar 42022: Nashrlar 32023: Nashrlar 32024: Nashrlar 42025: Nashrlar 22026: Nashrlar 2

h-indeks evolyutsiyasi

Yillar boʻyicha jamlangan h-indeks

0134520172018201920202021202220232024202520262017: h-indeks 12018: h-indeks 12019: h-indeks 22020: h-indeks 32021: h-indeks 32022: h-indeks 42023: h-indeks 42024: h-indeks 42025: h-indeks 42026: h-indeks 4

Eng koʻp iqtibos qilingan asarlar

  1. Effectiveness and safety of standardised shorter regimens for multidrug-resistant tuberculosis: individual patient data and aggregate data meta-analyses20174 iqtibos
  2. Overview of the current status of familial hypercholesterolaemia care in over 60 countries - The EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC)20182 iqtibos
  3. Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study20202 iqtibos
  4. Standardised shorter regimens <i>versus</i> individualised longer regimens for rifampin- or multidrug-resistant tuberculosis20191 iqtibos
  5. Calibration and discrimination of the Framingham Risk Score and the Pooled Cohort Equations20200 iqtibos
  6. Characteristics of children and adolescents with multidrug-resistant and rifampicin-resistant tuberculosis and their association with treatment outcomes: a systematic review and individual participant data meta-analysis20250 iqtibos
  7. An international multidisciplinary consensus statement on laparoscopic liver biopsy20260 iqtibos
  8. IDDF2026-ABS-0365 An international multidisciplinary consensus statement on laparoscopic liver biopsy20260 iqtibos